This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cramer's 'Mad Money' Recap: Next Week's Game Plan


Cramer explained that Covidian's medical device business has been dragged down by the pharma division, but will almost instantly get a higher multiple as a simpler, easier-to-understand entity. But that doesn't mean shareholders should sell Mallinckrodt on day one, noted Cramer. When Abbott Laboratories (ABT) split itself into two, both halves soared. Cramer expects the same to happen with Covidian.

Covidian is currently a $66 stock that sells at 15.7 times earnings, noted Cramer. After the split, the two companies could be worth $74, or 12% more than they are today.

Once Mallinckrodt hits $48 a share, however, Cramer said he'd be a seller of the stock, as the newly minted drug company will be faced with more generic competition starting in 2014.

Speculation Friday

For "Speculation Friday," Cramer turned the spotlight onto W.R. Grace (GRA), a company whose shares have risen 23% so far this year despite the fact that it's been in bankruptcy since 2011.

Cramer explained that Grace was forced into bankruptcy due to asbestos litigation that is now in its final stages. The bankruptcy is a blessing in disguise, however, because many mutual funds aren't allowed to own companies in bankruptcy. That means when Grace emerges as a new company in the fourth quarter there should be a ton of pent-up demand for the stock.

W.R. Grace is a specialty chemical maker made up of three divisions, Cramer continued. Its catalyst technology division makes additives for the oil and refining business as well as for chemical makers. It also has a construction products business and a materials technology segment that is similar to PPG (PPG) in making coatings.

Grace has always been a best of breed company with tons of pricing power, said Cramer. When it comes out of bankruptcy free of litigation, it will sport a lean balance sheet as well as the ability to offer shareholders a dividend.

How much is W.R. Grace worth? Cramer said adding up all the parts and subtracting the debt yields an $8 billion company, or $105 a share, which is a full 26% higher than where it trades today. Cramer said he expects shares to reach their full potential in just months after the bankruptcy is behind them.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs